Patent ID: 11894119
Assignee: RUMA GMBH
Field: IT methods for management (Electrical engineering)
Classification: CPC G  H | IPC G  H

Claim 0:
1. A method for using a pharmaceutical composition in endogenous marking of a urine sample, wherein the pharmaceutical composition contains no active substance but merely a combination of at least two marker substances and wherein the marker substances are polyethylene glycols with different molecular weights, characterized by the following steps:
Registering every individual dose of the pharmaceutical composition in its production and subsequent packaging in a blockchain, wherein all relevant actions of the parties involved in the process regarding this pharmaceutical composition are registered in the blockchain for seamless logging from production to intake of the pharmaceutical composition;
Marking of an outer packaging with a first digital code;
Scanning of the first digital code by a dispensing office;
Linking of patient data of a patient with data of an authorized person, wherein the blockchain links the units involved so that a coherent information chain results;
Starting an application software by the patient;
Scanning the first digital code by the application software;
Starting a video recording;
Presenting integrity of the outer packaging;
Taking a container with the pharmaceutical composition out of the outer packaging;
Scanning a second digital code on the container with the pharmaceutical composition;
Opening the container;
Taking the pharmaceutical composition out of the container;
Taking the pharmaceutical composition;
Termination of the video recording;
Transmission of the video recording to the authorized person and through the application software to the blockchain;
Validation of the documented intake by the authorized person.